News
![](https://www.vivebiotech.com/wp-content/uploads/2023/10/Imagen-1.jpg'))
11 October 2023
VIVEbiotech participates one more year in the Cell & Gene Meeting on the Mesa
VIVEbiotech is participating once again in the Cell & Gene Meeting on the Mesa congress in California.
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/10/Imagen.jpg'))
9 October 2023
VIVEbiotech featured in an article in BioPharm International
VIVEbiotech has been featured in an article in BioPharm International
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/09/VIVEbiotech_2.jpg'))
28 September 2023
VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation
An article featured by Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, has just been published by European Pharmaceutical Manufacturer.
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/09/2023_09_14-Medicine-Maker-Natalia.jpg'))
14 September 2023
The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde
The Medicine Maker has published an opinion article after interviewing Natalia Elizalde, VIVEbiotech´s Chief Business Development Officer.
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/08/Imagen-1.jpg'))
24 August 2023
VIVEbiotech will lead a session with speakers from top international companies during upcoming Biospain
Biospain is a biotechnology congress organized by AseBio - Asociación Española de Empresas Biotecnológicas and is held every two years in a...
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/08/ImagenDEF.jpg'))
14 August 2023
Contribution to an article defining the benefits of lentiviruses in BioPharm International
In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with...
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/07/Congress-in-Badajoz.jpeg'))
17 July 2023
VIVEbiotech participates in the XVI Annual Biotechnology Congress
Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023)...
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/07/Imagen.jpg'))
11 July 2023
VIVEbiotech contributes to accelerate the development of muscular dystrophies through the European MAGIC project
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international...
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/07/2023_01_25-Drug-Discovery-World-1-scaled.jpg'))
19 June 2023
VIVEbiotech interview on C> manufacturing trends at Drug Discovery World
VIVEbiotech participated in the ISCT, International Society for Cell & Gene Therapy´s (ISCT) Annual Meeting took place three weeks ago in beautiful Paris.
Read more![](https://www.vivebiotech.com/wp-content/uploads/2023/07/Imagen-3.jpg'))
13 June 2023
Gurutz Linazasoro, CEO of VIVEbiotech, participates in the Foro de Biociencia
Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled "Boosting science and research of high quality and impact" at the...
Read more